Markets sputter to a weak start, in the absence of any key triggers in the week to come, except for the flagging off of the earnings season, beginning 10th Jan when INFY and INDUSINDBK come up with how they have fared in the quarter ended Dec’13. The weekend too has had no surprises from the overseas markets, except the weakness in the Japanese equity markets that marketmen refer to as the outcome of the contra play that US and Japanese markets are clearly aligning themselves into.
Within the Indian equity market, PHARMA and TECHNOLOGY stocks continue to hog the attention of participants while some of the news-aided moves within the PSU PACK too are clearly visible within today’s session. MIDCAPS however continue the growing levels of momentum, albeit on a selective basis and not across the board. Ideal strategy would be to BUY into DIPS, as we move into a volatile phase with the earnings season setting in later this week. Business wealth management firms can await some activity in the coming week. Financial planning advisors can reap benefits from the stocks.